Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Documents similaires
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
par: Claudia Crimi, et autres
Publié: (2023-11-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
par: Giorgio Walter Canonica, et autres
Publié: (2020-08-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
par: Carla Rognoni, et autres
Publié: (2023-06-01) -
Asthma severity: the patient’s point of view
par: Gabriella Guarnieri, et autres
Publié: (2024-12-01) -
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
par: Giovanna Elisiana Carpagnano, et autres
Publié: (2023-10-01)